Why Is Chemring Group Down Today?

Chemring Group PLC shares fell 0.56% to 531.50p today, a decline of 3.00p, according to the supplied market data.

There was no new company announcement. Chemring's financial year ends on 31 October, and investors may be cautious ahead of full-year results, given a slower start to the year earlier in 2026.

Defence stocks can also move with geopolitical headlines.

Key Highlights

The order book reached a record £1.4bn, up 8%, at the half year.

H1 revenue rose 7%.

Around 91% of expected FY26 revenue was delivered or in the order book at 30 April.

The interim dividend rose 4% to 2.8p.

Chemring aims to double annual revenue to £1bn by 2030.

About Chemring Group PLC

Chemring is a defence and security technology company. It supplies countermeasures, energetic materials, sensors and cyber and electronic warfare capabilities to national defence organisations.

Its Roke business provides national security and cyber expertise.

LSE:CHG is led by chief executive Michael Ord.

Key Reasons Behind Today's Downtick

Earlier in the year, Chemring flagged a slower-than-expected start due to operational disruption in countermeasures production, now largely resolved. Revenue is more second-half weighted than a year ago.

Investors may be waiting for confirmation of full-year delivery.

With no news, today's dip appears routine.

Riding the Defence Spending Wave

Rising geopolitical tensions are driving increased defence spending across NATO and allied nations. Chemring says it expects this demand to persist well into the next decade.

Countermeasures and Energetics has driven growth, with its order cover improving to 84% from 64% a year earlier.

Expansion and New Products

Chemring is investing in energetics expansion projects, including in Norway. It launched the CORTEXA GUARDIAN counter-drone system in April 2026, with early sales in Sweden and the UK.

Financial Performance

In FY25, underlying operating profit rose 6% to £73.5m on revenue of £497.5m. Chemring expects full-year cash conversion of 80% to 85% in FY26.

Countermeasures and Energetics

Chemring's Countermeasures and Energetics business produces flares and other countermeasures that protect aircraft from missile threats, as well as energetic materials used in munitions and space applications.

Demand for these products has surged as countries replenish stockpiles and increase readiness. Revenue in this division rose 18% to £327m in FY25, and its order book grew 32% to £1.2bn.

Sensors and Information

The Sensors and Information division, which includes Roke, provides detection systems, cyber capabilities and electronic warfare expertise. Its revenue fell in FY25, but its order book grew, and it won a £22.5m STORM Missile Defence Centre order in early 2026.

Investment to Capture Growth

Chemring is investing heavily in new production capacity, particularly in energetics. Plant expansion costs in Norway have increased, which affects near-term cash, but the investments are designed to support the £1bn revenue ambition.

The company is also in discussions with the US about further opportunities, according to management.

Dividend

Chemring pays a modest but growing dividend, with the FY25 total payout rising 2.6% to 8.0p. The interim dividend for FY26 increased 4% to 2.8p.

Key Growth Catalysts

Defence spending growth, energetics capacity, counter-drone sales and the £1bn revenue ambition support the outlook.

Risks

Production disruption, contract timing, defence budget changes and capital spending costs are key risks.

Valuation

At 531.50p, Chemring has a market capitalisation of approximately £1.45bn.

Against FY25 underlying operating profit of £73.5m, the shares trade at roughly 20 times trailing operating profit, reflecting growth expectations.

What Investors Should Watch Next

Investors should watch full-year results in December, order intake and progress towards the 2030 ambition.

Conclusion

Chemring's 0.56% dip to 531.50p reflects caution ahead of year-end. A record order book and strong defence demand support the case.